6789-94-2

Basic information

• Product Name: 1-ETHYLPIPERIDIN-3-AMINE
• Synonyms: ASINEX-REAG BAS 14404183;3-AMINO-N-ETHYLPIPERIDINE;3-AMINO-1-ETHYLPIPERIDINE;1-ETHYLPIPERIDIN-3-AMINE;1-ETHYL-PIPERIDIN-3-YLAMINE;TIMTEC-BB SBB010256;1-Ethylpiperidin-3-amine 97%;1-Ethyl-3-piperidinamine
• CAS NO: 6789-94-2
• Molecular Formula: C₇H₁₆N₂
• Molecular Weight: 128.22
• EINECS: 229-857-0
• Mol File: 6789-94-2.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 155℃
• Flash Point: 61℃
• Appearance: /
• Density: 0.898
• Vapor Pressure: 3.08mmHg at 25°C
• Refractive Index: 1.4715
• Storage Temp.: -20°C Freezer
• Solubility: Methanol
• PKA: 11.06±0.20(Predicted)
• CAS DataBase Reference: 1-ETHYLPIPERIDIN-3-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-ETHYLPIPERIDIN-3-AMINE(6789-94-2)
• EPA Substance Registry System: 1-ETHYLPIPERIDIN-3-AMINE(6789-94-2)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22-37/38-41
• Safety Statements: 26-39
• HazardClass: IRRITANT
• Hazardous Substances Data: 6789-94-2(Hazardous Substances Data)

Usage

Uses

1-Ethyl-3-piperidinamine is an intermediate in the synthesis of 4-Amino-N-(1-ethyl-3-piperidinyl)-5-(ethylsulfonyl)-2-methoxybenzamide (A609495), which is an impurity of Amisulpride (A633250). Amisulpride EP Impurity G.

InChI:InChI=1/C7H16N2/c1-2-9-5-3-4-7(8)6-9/h7H,2-6,8H2,1H3

Upstream product

• 24059-81-2 N-(1-ethyl-[3]piperidyl)-acetamide 
• 213627-39-5 1-Ethyl-piperidin-3-one oxime 

Downstream Products

• 144128-42-7 7-Chloro-3-(3,4-dichloro-phenyl)-1-[(E)-1-ethyl-piperidin-3-ylimino]-10-hydroxy-1,3,4,10-tetrahydro-2H-acridin-9-one 
• 51218-14-5 N-(1-ethyl-piperidin-3-yl)-2-methoxy-5-sulfamoyl-benzamide 
• 4840-67-9 N-(1-Ethyl-piperidin-3-yl)-2-methoxy-5-nitro-benzamide 
• 110045-53-9 N-(4-Chloro-phenyl)-N'-[4-(1-ethyl-piperidin-3-ylamino)-6-trichloromethyl-[1,3,5]triazin-2-yl]-guanidine 
• 72811-07-5 C₂₀H₂₇N₅O₃S 
• 84332-20-7 2-Amino-4-methoxy-pyrimidine-5-carboxylic acid (1-ethyl-piperidin-3-yl)-amide 
• 130820-17-6 1-ethyl-3-(1-phenyl-2-propylamino)piperidine 
• 85037-14-5 [(E)-2-(4-Ethyl-5-methyl-thiazol-2-yl)-1-methyl-vinyl]-(1-ethyl-piperidin-3-yl)-amine 
• 130259-96-0 N-(1-ethyl-3-piperidinyl)-2-methoxy-5-(N-(4-toluenesulfonyl)-amino)benzamide 
• 130259-98-2 N-(1-ethyl-3-piperidinyl)-2-methoxy-5-(N,N-bis(4-toluenesulfonyl)amino)benzamide 
• 130259-92-6 5-Amino-N-(1-ethyl-piperidin-3-yl)-2-methoxy-benzamide 
• 130260-02-5 N-(1-ethyl-3-piperidinyl)-2-methoxy-5-(methylamino)benzamide 
• 130260-00-3 N-(1-ethyl-3-piperidinyl)-2-methoxy-5-(N-methyl-N-(4-toluenesulfonyl)amino)benzamide 
• 72232-11-2 2-((8-chloroquinolin-4-yl)amino)-N-(1-ethylpiperidin-3-yl)benzamide 

Relevant articles and documents

INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2

Pharmaceutical compositions containing organic compounds or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.

Separation of blood coagulation factors with non-activating polyelectrolytes

Blood coagulation factors such as Factor VIII are separated from admixture with other blood proteins without producing activation of said coagulation factors by contacting with a water-insoluble, cross-linked polyelectrolyte copolymer of (a) C2-18 unsaturated monomer and (b) C4-12 unsaturated polycarboxylic acid or anhydride which is partially substituted at its free carboxyl or anhydride sites with amine-imides and in which substantially all the remaining free carboxyl or anhydride sites are blocked with alkoxyalkylamine to form alkoxyalkylimide units.